Clinical Trials
7 trialsNCT05200559 2026-05-29
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
University of Pittsburgh
Phase 1/2 Active not recruiting
NCT06708429 2026-04-24
LYNX-EYE
San Raffaele University
Recruiting
NCT03050268 2026-04-23
SJFAMILY
St. Jude Children's Research Hospital
Recruiting
NCT07369986 2026-01-27
IMMUNE-SAVE
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Not yet recruiting
NCT05257057 2025-03-28
Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome
WellSpan Health
Completed
NCT04906382 2025-02-13
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT06549855 2024-08-12
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Peking University People's Hospital
Phase NA Not yet recruiting